United States was the largest of Alcon Inc’s 5 reported lines in fiscal 2025, at $9.31B — 45% of $20.64B.
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $7.79B | $8.62B | $9.02B | $9.31B | |||||
| Other | $7.31B | $7.77B | $8.26B | $8.82B | |||||
| Japan | $1.14B | $1.17B | $1.11B | $1.22B | |||||
| China | $948.00M | $1.05B | $1.12B | $1.14B | |||||
| Switzerland | $118.00M | $128.00M | $158.00M | $142.00M | |||||
| Total | $17.31B | $18.74B | $19.67B | $20.64B |
In fiscal 2025, which ended December 31, 2025, the 5 regions Alcon Inc reported in this breakdown added up to $20.64B. That was up 4.9% from $19.67B in fiscal 2024. United States was the largest region, at $9.31B or 45.1% of the total, followed by Other ($8.82B, 42.8%) and Japan ($1.22B, 5.9%). Together, the two largest regions made up 87.9% of this total.
Compared with fiscal 2024, Japan grew the fastest, rising 9.9% to $1.22B. Every sizeable region reported in both years grew. Over fiscal 2022 to 2025, revenue across these regions went from $17.31B to $20.64B, a compound annual growth rate of 6.0%. United States held a steady share of about 45.1%.
This breakdown covers every fiscal year from 2017 to 2025, as reported in Alcon Inc's annual filings.
Consumables was the largest of Alcon Inc’s 5 reported lines in fiscal 2025, at $6.06B — 29% of $20.64B.
| Products and services [axis] | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Consumables | $5.00B | $5.44B | $5.72B | $6.06B | |||||
| Contact Lenses | $4.38B | $4.80B | $5.22B | $5.54B | |||||
| Implantables | $3.45B | $3.41B | $3.55B | $3.56B | |||||
| Ocular Health | $2.83B | $3.31B | $3.41B | $3.60B | |||||
| Equipment/Other | $1.64B | $1.78B | $1.77B | $1.88B | |||||
| Equipment Other | — | — | — | — | |||||
| Total | $17.31B | $18.74B | $19.67B | $20.64B |
In fiscal 2025, which ended December 31, 2025, the 5 revenue lines Alcon Inc reported in this breakdown added up to $20.64B. That was up 4.9% from $19.67B in fiscal 2024. Consumables was the largest revenue line, at $6.06B or 29.3% of the total, followed by Contact Lenses ($5.54B, 26.8%) and Ocular Health ($3.60B, 17.4%). Together, the two largest revenue lines made up 56.2% of this total.
Compared with fiscal 2024, Equipment/Other grew the fastest, rising 6.2% to $1.88B. Every sizeable revenue line reported in both years grew. Over fiscal 2022 to 2025, revenue across these revenue lines went from $17.31B to $20.64B, a compound annual growth rate of 6.0%. Consumables held a steady share of about 29.3%.
The table also keeps 1 revenue line that Alcon Inc no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2017 to 2025, as reported in Alcon Inc's annual filings.
Surgical was the largest of Alcon Inc’s 2 reported lines in fiscal 2025, at $6.06B — 52% of $11.60B.
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Surgical | $5.00B | $5.44B | $5.72B | $6.06B | |||||
| Vision Care | $4.38B | $4.80B | $5.22B | $5.54B | |||||
| Total | $9.38B | $10.24B | $10.94B | $11.60B |
In fiscal 2025, which ended December 31, 2025, the 2 segments Alcon Inc reported in this breakdown added up to $11.60B. That is less than the $20.64B in its breakdown by region, so these segments do not account for all of its revenue that year. Surgical was the largest segment, at $6.06B or 52.2% of the total, followed by Vision Care ($5.54B, 47.8%).
Compared with fiscal 2024, Vision Care grew the fastest, rising 6.2% to $5.54B.
This breakdown covers every fiscal year from 2017 to 2025, as reported in Alcon Inc's annual filings.
Alcon Inc (ALC) breaks its revenue down by region, revenue line and segment. In fiscal 2025, its largest region was United States, with $9.31B or 45.1% of the total, followed by Other at $8.82B (42.8%).
United States was Alcon Inc's largest region in fiscal 2025, with $9.31B in revenue, 45.1% of the $20.64B reported across its 5 regions.
Consumables was Alcon Inc's largest revenue line in fiscal 2025, with $6.06B in revenue, 29.3% of the $20.64B reported across its 5 revenue lines.
Surgical was Alcon Inc's largest segment in fiscal 2025, with $6.06B in revenue, 52.2% of the $11.60B reported across its 2 segments.
Of the Alcon Inc regions reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Japan grew the fastest, rising 9.9% from $1.11B to $1.22B.
Every figure is taken from Alcon Inc's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by region covers fiscal 2017 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.